| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2096106A1 Novel polyamine derivatives |
| 09/02/2009 | EP2095828A1 Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease |
| 09/02/2009 | EP2095826A1 Nerve elongation promoter and elongation inhibitor |
| 09/02/2009 | EP2095824A1 A method for restoring BMP-receptor signaling in a cell |
| 09/02/2009 | EP2095823A1 GM-CSF for treating demyelination |
| 09/02/2009 | EP2095814A1 Nicotine withdrawal supported by medication |
| 09/02/2009 | EP2094730A2 Methods and materials related to anti-amyloid antibodies |
| 09/02/2009 | EP2094720A1 Selective inhibitors of neurotensin degrading enzymes |
| 09/02/2009 | EP2094711A1 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 09/02/2009 | EP2094709A1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists |
| 09/02/2009 | EP2094706A2 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 09/02/2009 | EP2094704A2 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 09/02/2009 | EP2094703A1 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 09/02/2009 | EP2094701A2 Compounds and methods for kinase modulation, and indications therefor |
| 09/02/2009 | EP2094690A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 09/02/2009 | EP2094685A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors |
| 09/02/2009 | EP2094684A2 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin 2-ones as cb1 receptor modulators |
| 09/02/2009 | EP2094677A1 Thiadiazole derivatives for the treatment of neuro-degenerative diseases |
| 09/02/2009 | EP2094675A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| 09/02/2009 | EP2094674A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| 09/02/2009 | EP2094668A2 4-imidazolines as taar's ligands |
| 09/02/2009 | EP2094657A1 Azabicyclic compounds as serotonine, dopamine and norepinephrine re-uptake inhibitors |
| 09/02/2009 | EP2094645A1 2-hydroxy-1,3-diaminopropane derivatives |
| 09/02/2009 | EP2094265A1 Pyrroloy[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
| 09/02/2009 | EP2094115A1 Dietary and pharmaceutical compositions comprising a sage extract containing a mixture of tricyclic diterpenes and their derivatives and their uses |
| 09/02/2009 | EP1937672B1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 09/02/2009 | EP1928448B1 ASSOCIATION OF ß3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC USE THEREOF |
| 09/02/2009 | EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 09/02/2009 | EP1891064B1 N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as ccr1 antagonists |
| 09/02/2009 | EP1856052B1 Nk1 antagonists |
| 09/02/2009 | EP1758860B1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 09/02/2009 | EP1758852B1 Substituted cyclopentene compounds |
| 09/02/2009 | EP1641763B1 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/02/2009 | EP1496890B1 Substituted beta-aminoalcohols used as medicaments |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1317479B1 Methods and compositions for diseases associated with amyloidosis |
| 09/02/2009 | EP1300395B1 4-substituted piperidine compound |
| 09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
| 09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
| 09/02/2009 | EP1091750B1 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same |
| 09/02/2009 | EP1087991B1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 09/02/2009 | CN101519385A Small molecule compound being capable of promoting proliferation of stem cells and function thereof |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518638A Pearl pill and method for preparing same |
| 09/02/2009 | CN101518636A Drug for treating long-standing headache and preparation method thereof |
| 09/02/2009 | CN101518619A Compound brain activation and comfort capsule and quality control method thereof |
| 09/02/2009 | CN101518604A Capsule for treating infantile cerebral palsy and preparation method thereof |
| 09/02/2009 | CN101518583A Chinese patent medicament for external application with functions of warming meridians and activating collaterals |
| 09/02/2009 | CN101518581A Compound gardenia oil soft capsule and method for preparing same |
| 09/02/2009 | CN101518580A Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof |
| 09/02/2009 | CN101518575A Traditional Chinese medicine for treating diabetic insomnia |
| 09/02/2009 | CN101518571A Traditional Chinese medical composition with the function of brain strengthening and tranquilization and used for treating neurasthenia and preparation method thereof |
| 09/02/2009 | CN101518562A Non-oral preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518561A Oral medicinal preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518515A Cytidine disodium triphosphate freeze-dried powder-injection for injection |
| 09/02/2009 | CN101518353A Alcohol-detoxication inflammation-relieving liver-protection beverage and preparation method thereof |
| 09/02/2009 | CN101518352A Antialcoholism health drink and preparation method thereof |
| 09/02/2009 | CN101518351A Weak alkali plant alcohol intoxication-alleviating beverage and method for preparing same |
| 09/02/2009 | CN101518330A Drink before wine and method for making same |
| 09/02/2009 | CN101518204A Tissue-culturing and reproduction method of Valeriana officinalis Linn |
| 09/02/2009 | CN101518188A Seed reproduction and planting method of Valeriana officinalis L. |
| 09/02/2009 | CN100535106C Method for differentiating mesenchymal stem cells into neural cells |
| 09/02/2009 | CN100534997C C-aryl glucoside SGLT2 inhibitors and method |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/02/2009 | CN100534983C Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 09/02/2009 | CN100534530C Vehicle for topical delivery of anti-inflammatory compounds |
| 09/02/2009 | CN100534482C Soft capsule for treating vascular headaehe |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/02/2009 | CN100534420C An oral administered medicine for treating depression-Jin Yu Kang |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy |
| 09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 09/01/2009 | US7582666 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582651 Pyrrolopyridine derivative and use thereof |
| 09/01/2009 | US7582649 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors |
| 09/01/2009 | US7582625 -(4-Hydroxy-3,5-dimethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; headaches; non-insulin dependent diabetes; antidiabetic agents; cardiovascular/nervous system disorders; antiinflammatory agents |
| 09/01/2009 | US7582619 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 09/01/2009 | US7582425 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin |
| 09/01/2009 | US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582311 Comprising hyaluronic acid or sodium hyaluronate dissolved in physiological buffer at concentration of 0.01-3 percent weight per volume and particles comprising first component biologically active agent and second component biocompatible polymeric matrix; use of 23-gauge or smaller bore needle |
| 09/01/2009 | CA2490115C Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 09/01/2009 | CA2467973C Pyridine derivatives as nmda receptor ligands |
| 09/01/2009 | CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/01/2009 | CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence |
| 09/01/2009 | CA2417727C Fentanyl composition for nasal administration |
| 09/01/2009 | CA2400804C Stable emulsion compositions of cycloalkene derivatives |
| 09/01/2009 | CA2396209C The use of mirtazapine for the treatment of sleep disorders |
| 09/01/2009 | CA2393344C Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/01/2009 | CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof |